DAX21.717 -3,0%ESt505.113 -3,6%Top 10 Crypto11,40 -5,7%Dow40.819 -3,3%Nas16.650 -5,4%Bitcoin74.200 -2,0%Euro1,1025 +1,8%Öl70,25 -4,3%Gold3.109 -0,8%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Tesla A1CX3T NVIDIA 918422 Rheinmetall 703000 Amazon 906866 Apple 865985 RENK RENK73 Mercedes-Benz Group (ex Daimler) 710000 Volkswagen (VW) vz. 766403 Lufthansa 823212 Nike 866993 thyssenkrupp 750000 Microsoft 870747 Novo Nordisk A3EU6F HENSOLDT HAG000 Bayer BAY001
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Trump verkündet riesiges Zollpaket: DAX schließt tiefrot -- US-Börsen knicken ein -- Teils kräftige Verluste in Asien -- Goldpreis, Aktien von Mag 7, Banken, Sportartikeln und Autokonzernen im Fokus
Top News
Angespannte Stimmung in New York: NASDAQ 100 fällt nachmittags deutlich Angespannte Stimmung in New York: NASDAQ 100 fällt nachmittags deutlich
Verluste in New York: S&P 500-Anleger nehmen am Nachmittag Reißaus Verluste in New York: S&P 500-Anleger nehmen am Nachmittag Reißaus
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Filament Health Aktie

NeuKaufenVerkaufen
0,0005 EUR -0,0025 EUR -83,33 %
FSE
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Bei einem anderen Broker handelnSmartphone

Marktkap.2,53 Mio. EUR

WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA3CY3J

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINCA31685W1068

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolFLHLF

Filament Health Aktien News

DatumMeistgelesen
finanzen.netFilament Health öffnete die Bücher zum abgelaufenen Quartal
PR NewswireFILAMENT HEALTH REPORTS Q4 AND YEAR END 2024 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
PR NewswireFILAMENT HEALTH ANNOUNCES POSITIVE DATA FROM PHASE 2 STUDY OF PEX010 IN PATIENTS WITH ALCOHOL USE DISORDER
PR NewswireFILAMENT HEALTH ANNOUNCES SHIPMENT OF BOTANICAL PSILOCYBIN TO THE UNIVERSITY OF WISCONSIN-MADISON
PR NewswireFILAMENT HEALTH ANNOUNCES IMPORT OF COCA LEAF FROM PERU BY JOINT VENTURE MAGDALENA BIOSCIENCES
PR NewswireFILAMENT HEALTH ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
PR NewswireFILAMENT HEALTH ANNOUNCES ISSUANCE OF COMMON SHARES TO NEGEV CAPITAL INVESTMENTS LIMITED PURSUANT TO ADVISORY AGREEMENT
PR NewswireFILAMENT HEALTH ANNOUNCES SECOND QUARTER 2024 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
PR NewswireFILAMENT HEALTH ANNOUNCES MAJOR INTELLECTUAL PROPERTY EXPANSION
PR NewswireFILAMENT HEALTH ANNOUNCES CLOSING OF WARRANT EXERCISE, NOTE CONVERSION AND CONCURRENT PRIVATE PLACEMENT OF COMMON SHARES
PR NewswireFILAMENT HEALTH ANNOUNCES AUTHORIZATION OF PHASE 2 CLINICAL TRIAL FOR PEX010 IN THE TREATMENT OF METHAMPHETAMINE USE DISORDER
PR NewswireFILAMENT HEALTH ANNOUNCES WARRANT EXERCISE AND NOTE CONVERSION BY NEGEV CAPITAL AND CONCURRENT PRIVATE PLACEMENT OF COMMON SHARES TO BENJAMIN LIGHTBURN, CHIEF EXECUTIVE OFFICER
PR NewswireFILAMENT HEALTH ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
PR NewswireFILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS
PR NewswireFILAMENT HEALTH TO DISCUSS ITS DRUG DEVELOPMENT PLATFORM IN FIRESIDE CHAT WITH WATER TOWER RESEARCH ON APRIL 4, 2024 AT 12PM ET
PR NewswireFILAMENT HEALTH REPORTS Q4 AND YEAR END 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
PR NewswireFILAMENT HEALTH ANNOUNCES APPOINTMENT OF MICHAEL MESSINGER TO ITS BOARD OF DIRECTORS
PR NewswireFILAMENT HEALTH ANNOUNCES SHIPMENTS OF BOTANICAL PSILOCYBIN TO FOUR COUNTRIES FOR CLINICAL INVESTIGATION
PR NewswireFILAMENT HEALTH COMPLETES THE FIRST EXPORT OF BOTANICAL PSILOCYBIN TO ISRAEL
PR NewswireFILAMENT HEALTH ANNOUNCES FDA OPENING OF INVESTIGATIONAL NEW DRUG APPLICATION FOR SUBSTANCE USE DISORDERS
PR NewswireFILAMENT HEALTH COMPLETES THE FIRST EXPORT OF BOTANICAL PSILOCYBIN TO AUSTRALIA
PR NewswireFILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS
PR NewswireFILAMENT HEALTH ANNOUNCES TERMINATION OF PROPOSED BUSINESS COMBINATION WITH JUPITER ACQUISITION CORPORATION
PR NewswireFILAMENT HEALTH ANNOUNCES TERMINATION OF SHAREHOLDER MEETING AND ENGAGEMENT OF DONOHOE ADVISORY FOR COMPLIANCE EXPERTISE
PR NewswireFILAMENT HEALTH ANNOUNCES ADJOURNMENT OF SPECIAL MEETING
PR NewswireFILAMENT HEALTH FILES AMENDED PRO FORMA FINANCIAL STATEMENTS
PR NewswireFILAMENT HEALTH SIGNS NON-BINDING TERM SHEET FOR CONVERTIBLE NOTE IN CONNECTION WITH PLANNED BUSINESS COMBINATION
PR NewswireFILAMENT HEALTH ANNOUNCES THIRD QUARTER 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
PR NewswireFILAMENT HEALTH AND NASDAQ-LISTED SPAC JUPITER ACQUISITION CORPORATION ANNOUNCE FORM F-4 REGISTRATION STATEMENT DECLARED EFFECTIVE BY THE U.S. SECURITIES AND EXCHANGE COMMISSION AND MAILING OF DEF...
PR NewswireFILAMENT HEALTH ANNOUNCES HEALTH CANADA AUTHORIZATION FOR PHASE 2 CLINICAL TRIAL STUDYING BOTANICAL PSILOCYBIN FOR OPIOID USE DISORDER
PR NewswireFILAMENT HEALTH AND JAGUAR HEALTH JOINT VENTURE MAGDALENA BIOSCIENCES COMPLETES IMPORT OF COCA LEAF FROM PERU
PR NewswireFILAMENT HEALTH ENTERS LICENSING AGREEMENT WITH RESET PHARMA
PR NewswireFILAMENT HEALTH AND NASDAQ-LISTED SPAC JUPITER ACQUISITION CORP. ANNOUNCE FILING OF SEC REGISTRATION STATEMENT
PR NewswireFILAMENT HEALTH ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS AND REFILES Q1 2023 INTERIM FINANCIAL STATEMENTS AND MD&A
PR NewswireFILAMENT HEALTH ANNOUNCES FDA APPROVAL OF TWO CLINICAL TRIALS STUDYING ITS BOTANICAL PSILOCYBIN DRUG CANDIDATE PEX010
PR NewswireFILAMENT HEALTH ANNOUNCES UPSIZING AND CLOSING OF $2,500,000 NON-BROKERED PRIVATE PLACEMENT FINANCING
PR NewswireFILAMENT HEALTH CORP. ANNOUNCES NON-BROKERED PRIVATE PLACEMENT UNIT OFFERING OF UP TO C$2,000,000
PR NewswireFILAMENT HEALTH CORP. TO LIST ON NASDAQ THROUGH BUSINESS COMBINATION WITH JUPITER ACQUISITION CORPORATION
PR NewswireFILAMENT HEALTH ANNOUNCES CHANGE OF AUDITOR
PR NewswireFILAMENT HEALTH TO SUPPLY PSILOCYBIN FOR RECIPIENTS OF THE CANADIAN INSTITUTES OF HEALTH RESEARCH PSILOCYBIN OPERATING GRANTS
Wer­bung

Filament Health News

Filament Health News: auf dieser Seite finden Sie alle Filament Health News und Nachrichten zur Filament Health Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Filament Health News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Filament Health News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.